The current use of botulinum toxin.
Botulinum toxin is the most potent neurotoxin known, and has been in clinical use since the late 1970s. The toxin inhibits the release of acetylcholine from nerve terminals by inhibiting transport of the synaptic vesicles, thus causing functional denervation lasting up to 6 months. Our understanding of the mechanism of action of the toxin and the spectrum of diseases treatable with this agent continues to increase. Efficacy has been demonstrated in hemifacial spasm, dystonia, spasticity, hyperhidrosis and other conditions. Alternative serotypes are used in some centres, generally after the development of immunoresistance to the standard toxin (serotype A), and are likely to be in routine use in the near future. This paper reviews the history, pharmacology and current uses of botulinum toxin.
Mahant
N
N
Department of Neurology, Westmead Hospital, Westmead, NSW, Australia.
Clouston
P D
PD
Lorentz
I T
IT
D000818:Animals; D018726:Anti-Dyskinesia Agents / Q000191:economics / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000191:economics / Q000627:therapeutic use*; D004351:Drug Resistance; D004421:Dystonia / Q000188:drug therapy*; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy*
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins